199 related articles for article (PubMed ID: 20133280)
1. Alkylating agents in membranous nephropathy: efficacy proven beyond doubt.
Hofstra JM; Wetzels JF
Nephrol Dial Transplant; 2010 Jun; 25(6):1760-6. PubMed ID: 20133280
[No Abstract] [Full Text] [Related]
2. Chlorambucil-induced acute hepatic failure in a patient with membranous nephropathy.
Patel SP; Nast CC; Adler SG
Am J Kidney Dis; 2000 Aug; 36(2):401-4. PubMed ID: 10922320
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of immunosuppressive treatment in patients with membranous nephropathy and renal insufficiency.
Wetzels JF; Reichert LJ
Kidney Int Suppl; 1997 Oct; 61():S63-6. PubMed ID: 9328969
[No Abstract] [Full Text] [Related]
4. [The immunosuppressive agents in rheumatology. Indications, results and problems of long-term surveillance].
Kahn MF; De Seze S
Ann Med Interne (Paris); 1974; 125(6-7):497-506. PubMed ID: 4216281
[No Abstract] [Full Text] [Related]
5. A difficult trade off for adults with membranous nephropathy.
BMJ; 2013 Jan; 346():f248. PubMed ID: 23325868
[No Abstract] [Full Text] [Related]
6. The treatment of idiopathic membranous nephropathy: a dilemma or a conundrum?
Glassock RJ
Am J Kidney Dis; 2004 Sep; 44(3):562-6. PubMed ID: 15332231
[No Abstract] [Full Text] [Related]
7. Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.
Ren S; Wang Y; Xian L; Toyama T; Jardine M; Li G; Perkovic V; Hong D
PLoS One; 2017; 12(9):e0184398. PubMed ID: 28898290
[TBL] [Abstract][Full Text] [Related]
8. Chlorambucil-induced cytomegalovirus infection: a case report.
López-Lluva MT; de la Nieta-García MD; Piqueras-Flores J; Arambarri-Segura M; Martínez-Calero A; Rivera-Hernández F
J Med Case Rep; 2014 Aug; 8():280. PubMed ID: 25142684
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of membranous nephropathy with chronic renal insufficiency].
Passerini P; Leoni A
G Ital Nefrol; 2008; 25 Suppl 44():76-82. PubMed ID: 19048590
[TBL] [Abstract][Full Text] [Related]
10. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
Branten AJ; Wetzels JF
Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic abnormalities and therapy-related myelodysplastic syndromes in rheumatic disease.
McCarthy CJ; Sheldon S; Ross CW; McCune WJ
Arthritis Rheum; 1998 Aug; 41(8):1493-6. PubMed ID: 9704650
[TBL] [Abstract][Full Text] [Related]
12. Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy with strong risk factors for progression.
Hebert LA; Rovin BH; Agarwal AK; Spetie DN
Am J Kidney Dis; 2005 Apr; 45(4):788-9; author replyy 789-90. PubMed ID: 15806488
[No Abstract] [Full Text] [Related]
13. Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults.
Ponticelli C; Passerini P
Clin Nephrol; 1991; 35 Suppl 1():S16-21. PubMed ID: 1860261
[TBL] [Abstract][Full Text] [Related]
14. [Indications for immunosuppressive treatment in kidney diseases of children].
Wojnarowski M; Wyszyńska T
Pediatr Pol; 1969 May; 44(5):525-30. PubMed ID: 4183009
[No Abstract] [Full Text] [Related]
15. Corticosteroids, cyclophosphamide, and chlorambucil therapy of membranous nephropathy.
Passerini P; Ponticelli C
Semin Nephrol; 2003 Jul; 23(4):355-61. PubMed ID: 12923723
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy.
Boumpas DT; Tassiulas IO; Fleisher TA; Vaughan E; Piscitelli S; Kim Y; Pucino F; Balow JE; Austin HA
Clin Nephrol; 1999 Aug; 52(2):67-75. PubMed ID: 10480216
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
Idasiak-Piechocka I; Oko A; Łochyńska-Bielecka K; Skrobańska B
Kidney Blood Press Res; 2009; 32(4):263-7. PubMed ID: 19776643
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
du Buf-Vereijken PW; Wetzels JF
Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
[TBL] [Abstract][Full Text] [Related]
19. Delayed cross-reactivity between cyclophosphamide and chlorambucil.
Ben Fredj N; Aouam K; Chaabane A; Njim L; Boughattas N
J Clin Pharmacol; 2012 May; 52(5):771-4. PubMed ID: 21956606
[No Abstract] [Full Text] [Related]
20. Drug therapy. Immunosuppressive agents. I.
Kaplan SR; Calabresi P
N Engl J Med; 1973 Nov; 289(18):952-5. PubMed ID: 4582749
[No Abstract] [Full Text] [Related]
[Next] [New Search]
